All In Biotech

Drug Trial Radar · NCT03021499

Aurinia Renal Response in Active Lupus With Voclosporin

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis

Last checked: Nov 19, 2026Latest source record: Mar 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 358 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

358

Actual

Start

May 17, 2017

Primary completion

Sep 24, 2019

Study completion Oct 10, 2019

Sponsor

Lead sponsor
Aurinia Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jan 16, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.

Conditions

  • Lupus Nephritis

Interventions

  • VoclosporinDrug

    calcineurin inhibitor

  • Placebo Oral CapsuleDrug

    matching placebo capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adjudicated Renal Response at Week 52Time frame: 52 Weeks

Locations

185 sites in 31 countries. Site status is shown where the registry gives one.

  • AURORA Investigative Center

    Huntsville, Alabama

  • AURORA Investigative Center

    Phoenix, Arizona

  • AURORA Investigative Center

    Phoenix, Arizona

  • AURORA Investigative Center

    Beverly Hills, California

  • AURORA Investigative Center

    Los Angeles, California

  • AURORA Investigative Center

    Los Angeles, California

  • AURORA Investigative Center

    Palo Alto, California

  • AURORA Investigative Center

    Thousand Oaks, California

  • AURORA Investigative Center

    Torrance, California

  • AURORA Investigative Center

    Aurora, Colorado

  • AURORA Investigative Center

    Denver, Colorado

  • AURORA Investigative Center

    New Haven, Connecticut

  • AURORA Investigative Center

    Clearwater, Florida

  • AURORA Investigative Center

    DeBary, Florida

  • AURORA Investigative Center

    Fort Lauderdale, Florida

  • AURORA Investigative Center

    Fort Myers, Florida

  • AURORA Investigative Center

    Miami, Florida

  • AURORA Investigative Center

    Orlando, Florida

  • AURORA Investigative Center

    Winter Park, Florida

  • AURORA Investigative Center

    Atlanta, Georgia

  • AURORA Investigative Center

    Columbus, Georgia

  • AURORA Investigative Center

    Lawrenceville, Georgia

  • AURORA Investigative Center

    Chicago, Illinois

  • AURORA Investigative Center

    Louisville, Kentucky

  • AURORA Investigative Center

    Baton Rouge, Louisiana

  • AURORA Investigative Center

    New Orleans, Louisiana

  • AURORA Investigative Center

    Boston, Massachusetts

  • AURORA Investigative Center

    Detroit, Michigan

  • AURORA Investigative Center

    Grand Blanc, Michigan

  • AURORA Investigative Center

    Rochester, Minnesota

  • AURORA Investigative Center

    St Louis, Missouri

  • AURORA Investigative Center

    Las Vegas, Nevada

  • AURORA Investigative Center

    Newark, New Jersey

  • AURORA Investigative Center

    Great Neck, New York

  • AURORA Investigative Center

    New York, New York

  • AURORA Investigative Center

    New York, New York

  • AURORA Investigative Center

    New York, New York

  • AURORA Investigative Center

    Syracuse, New York

  • AURORA Investigative Center

    Chapel Hill, North Carolina

  • AURORA Investigative Center

    Charlotte, North Carolina

Showing 40 of 185 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.